zidovudine has been researched along with 3'-azido-2',3'-dideoxyguanosine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N | 1 |
Amblard, F; Asif, G; Bondada, L; Coats, SJ; Detorio, M; Fromentin, E; Mellors, JW; Obikhod, A; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Whitaker, T; Zhang, HW | 1 |
Cui, H; Gilbert, IH; González-Pacanowska, D; Ruiz-Pérez, LM | 1 |
Freeman, GA; Rideout, JL; Shaver, SR; Short, SA | 1 |
Harada, Y; Liu, X; Mizushina, Y; Ogawara, T; Ogimura, Y; Saneyoshi, M; Takahashi, H; Yamaguchi, T | 1 |
Asif, G; Coats, SJ; Detorio, M; Koontz, D; Mellors, JW; Meteer, JD; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Zhang, HW | 1 |
6 other study(ies) available for zidovudine and 3'-azido-2',3'-dideoxyguanosine
Article | Year |
---|---|
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2009 |
Synthesis and evaluation of 3'-azido-2',3'-dideoxypurine nucleosides as inhibitors of human immunodeficiency virus.
Topics: Anti-HIV Agents; Dideoxynucleosides; Glycosylation; HIV Reverse Transcriptase; Humans; Lymphocytes | 2010 |
Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum.
Topics: Antimalarials; Enzyme Inhibitors; Humans; Nucleoside-Phosphate Kinase; Nucleosides; Plasmodium falciparum; Prodrugs; Zidovudine | 2010 |
2-amino-9-(3-azido-2,3-dideoxy-beta-D-erythro-pentofuranosyl)-6-substituted-9H-purines: synthesis and anti-HIV activity.
Topics: Antiviral Agents; Cell Line, Transformed; Cytopathogenic Effect, Viral; Dideoxynucleosides; Guanosine; HIV-1; Humans; Lactobacillus; Pentosyltransferases; Purines; Structure-Activity Relationship; T-Lymphocytes; Thymidine; Zidovudine | 1995 |
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Topics: Antineoplastic Agents; Cell Proliferation; Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; DNA; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Telomerase; Telomere; Zidovudine | 2007 |
The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Azides; Base Sequence; Dideoxyadenosine; Dideoxynucleosides; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Zalcitabine; Zidovudine | 2011 |